Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1988-08-02 to 1989-01-11
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1989
Report date:
1980

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
EPA OPP 81-1 (Acute Oral Toxicity)
Version / remarks:
November 1984
Deviations:
no
Qualifier:
according to guideline
Guideline:
EPA OTS 798.1175 (Acute Oral Toxicity)
Version / remarks:
July 1987
Deviations:
no
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
1-[(4-chlorophenyl)methyl]-1-cyclopentyl-3-phenylurea
EC Number:
266-096-3
EC Name:
1-[(4-chlorophenyl)methyl]-1-cyclopentyl-3-phenylurea
Cas Number:
66063-05-6
Molecular formula:
C19H21ClN2O
IUPAC Name:
1-[(4-chlorophenyl)methyl]-1-cyclopentyl-3-phenylurea
Specific details on test material used for the study:
White powder

Test animals

Species:
rat
Strain:
Sprague-Dawley
Remarks:
CD(SD)BR
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Females nulliparous and non-pregnant: yes
- Age at study initiation: approximately 15-18 weeks.
- All animals were fasted overnight prior to dosing.
- Housing: Animals were housed individually in stainless steel cages suspended over deotized animal cage board (DACB) bedding. Bedding was changed three times weekly and rats were transferred to clean cages every three weeks.
- Diet: ad libitum
- Water: municipal, ad libitum
- Acclimation period: at least six days.
- Method of randomisation in assigning animals to test and control groups: Rats were assigned to cages from a list of computer-generated random numbers. Animals were assigned to dose groups from consecutively numbered cages.

ENVIRONMENTAL CONDITIONS
- Temperature: 18 to 26°C
- Humidity: 40 to 70%
- Photoperiod: 12-hour light/dark cycle.

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
polyethylene glycol
Remarks:
PEG 400
Details on oral exposure:
DOSE VOLUME APPLIED: 10 mL/kg
Doses:
5000 mg/kg bw
No. of animals per sex per dose:
5/sex/group
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days.
- Frequency of observations and weighing: twice daily during the week and once daily on weekends. Rats were weighed on the day of treatment and on days 7 and 14 after treatment.
- Necropsy of survivors performed: yes
All animals were subjected to a gross pathologic examination as soon as possible following their death. Survivors were sacrificed by CO2 asphyxiation on day 14 after treatment.
- Clinical signs including body weight: The weight range for all animals was within ±20% of the mean for each sex.

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 5 000 mg/kg bw
Based on:
test mat.
Mortality:
No deaths occurred at the oral limit dose (5000 mg/kg bw).
Clinical signs:
other: Urine stain
Body weight:
other body weight observations
Remarks:
Body weight increased for all animals from days 0-7 and for all but one female (8 g loss) from days 7-14.
Gross pathology:
No gross lesions were observed at necropsy.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Pencycuron does not require classification for acute oral toxicity in any CLP category on the basis of this study. For both males and females the acute oral LD50 was >5000 mg/kg bw and the no-observed-effect level was <5000 mg/kg bw.
Executive summary:

The acute oral toxicity of pencycuron was tested in young adult male and female (5/sex) Sprague-Dawley rats using the oral limit dose (5000 mg/kg bw). Pencycuron was administered by gavage in polyethylene glycol (10 mL/kg). Animals were observed for 14 days post-dosing for mortality and clinical signs. Body weights were recorded on the day of treatment (day 0) and on days 7 and 14. On day 14 the animals were sacrificed and a gross necropsy was performed.


 


No deaths were observed at the oral limit dose, therefore, LD50 estimates were not determined. Treatment related clinical signs, consisting of urine stain in four animals (three males and one female) and anal stain in one male, were resolved by day 3. Body weights increased for all animals from days 0-7 and for all but one female from days 7-14. No treatment-related gross lesions were observed at necropsy. For both males and females, the oral LD50 for pencycuron was >5000 mg/kg bw.